Veracyte (VCYT) Total Current Liabilities (2012 - 2026)

Veracyte has disclosed Total Current Liabilities across 15 years of filings, most recently posting $56.1 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $56.1 million, down 25.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $56.1 million (down 25.3% YoY), and the FY2025 annual result was $59.9 million, down 23.78% from the prior year.
• Total Current Liabilities came in at $56.1 million for Q1 2026 at Veracyte, down from $59.9 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $78.6 million in Q4 2024 to a low of $56.0 million in Q1 2023.
• The 5-year median for Total Current Liabilities is $61.2 million (2023), against an average of $64.4 million.
• Across the five-year window, Total Current Liabilities soared 91.21% in 2022 and fell 25.3% in 2026, its largest moves.
• Veracyte's Total Current Liabilities stood at $62.6 million in 2022, then dropped by 2.19% to $61.2 million in 2023, then gained by 28.4% to $78.6 million in 2024, then dropped by 23.78% to $59.9 million in 2025, then decreased by 6.38% to $56.1 million in 2026.
• The last three Total Current Liabilities figures came in at $56.1 million (Q1 2026), $59.9 million (Q4 2025), and $72.2 million (Q3 2025), per Business Quant data.